Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

The obesity drug liraglutide cut migraine days in half in a small trial, though more research is needed to exclude the ...

Liraglutide, a member of the family of blockbuster weight-loss drugs, reduces headaches by half in a small study.

A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.

“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...

A common diabetes drug may be the next big thing for migraine relief. In a clinical study, obese patients with chronic ...

Now, a groundbreaking study from researchers at Boston Children’s Hospital and Harvard Medical School is offering a potential ...

Migraines are a common ailment worldwide, affecting nearly 15% of the global population. At times, they can be debilitating enough to interfere with daily activities. Despite a multitude of treatment ...

A new study finds that the diabetes drug liraglutide significantly reduced monthly migraine days in patients with obesity and ...

Around five million Australians suffer from migraines, with women three times more likely to be affected than men ...

A small, early-stage study published in the journal Headache suggested a diabetes drug may ease migraines by lowering ...